BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10068058)

  • 1. Signalling by cytokines interacting with the interleukin-2 receptor gamma chain.
    Demoulin JB; Renauld JC
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):243-56. PubMed ID: 10068058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
    J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
    Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
    J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the involvement of LCK and MAP kinase (ERK-1) in the signal transduction mechanism of interleukin-15.
    Adunyah SE; Wheeler BJ; Cooper RS
    Biochem Biophys Res Commun; 1997 Mar; 232(3):754-8. PubMed ID: 9126349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein and lipid kinase activation cascades in interleukin-2 receptor signalling.
    Williamson P; Merida I; Gaulton G
    Semin Immunol; 1993 Oct; 5(5):337-44. PubMed ID: 8260650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors.
    Haan C; Rolvering C; Raulf F; Kapp M; Drückes P; Thoma G; Behrmann I; Zerwes HG
    Chem Biol; 2011 Mar; 18(3):314-23. PubMed ID: 21439476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell factor and IL-2 act synergistically in inducing intraepithelial lymphocyte proliferation and cytokine production: upregulation of the IL-2 receptor gamma-chain and signaling via JAK-3.
    Wang T; Alam R; Langley KE; Klimpel GR
    Cell Immunol; 2000 Oct; 205(1):62-71. PubMed ID: 11078608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane and intracellular signalling by interleukin-4: receptor dimerization and beyond.
    Duschl A; Sebald W
    Eur Cytokine Netw; 1996; 7(1):37-49. PubMed ID: 8704094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.
    Malabarba MG; Rui H; Deutsch HH; Chung J; Kalthoff FS; Farrar WL; Kirken RA
    Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):865-72. PubMed ID: 8920992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical sites for the interaction between IL-2Rgamma and JAK3 and the following signaling.
    Tang W; Huo H; Zhu J; Ji H; Zou W; Xu L; Sun L; Zheng Z; Theze J; Liu X
    Biochem Biophys Res Commun; 2001 May; 283(3):598-605. PubMed ID: 11341766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 and IFN-gamma synergistically increase total polymeric IgA receptor levels in human intestinal epithelial cells. Role of protein tyrosine kinases.
    Denning GM
    J Immunol; 1996 Jun; 156(12):4807-14. PubMed ID: 8648128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of IL-2 signaling.
    Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Sugamura K
    Leukemia; 1997 Apr; 11 Suppl 3():416-7. PubMed ID: 9209410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-regulation of JAK and Src kinases.
    Ingley E; Klinken SP
    Growth Factors; 2006 Mar; 24(1):89-95. PubMed ID: 16393697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate affinity interleukin-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway.
    González-García A; Mérida I; Martinez-A C; Carrera AC
    J Biol Chem; 1997 Apr; 272(15):10220-6. PubMed ID: 9092570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines: shared receptors, distinct functions.
    DiSanto JP
    Curr Biol; 1997 Jul; 7(7):R424-6. PubMed ID: 9210372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.
    Johnston JA; Bacon CM; Riedy MC; O'Shea JJ
    J Leukoc Biol; 1996 Oct; 60(4):441-52. PubMed ID: 8864127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals.
    Chen M; Cheng A; Chen YQ; Hymel A; Hanson EP; Kimmel L; Minami Y; Taniguchi T; Changelian PS; O'Shea JJ
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6910-5. PubMed ID: 9192665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers.
    Hornakova T; Staerk J; Royer Y; Flex E; Tartaglia M; Constantinescu SN; Knoops L; Renauld JC
    J Biol Chem; 2009 Mar; 284(11):6773-81. PubMed ID: 19139102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The docking molecule gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common gamma chain-using cytokines.
    Gadina M; Sudarshan C; Visconti R; Zhou YJ; Gu H; Neel BG; O'Shea JJ
    J Biol Chem; 2000 Sep; 275(35):26959-66. PubMed ID: 10849428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.